Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 698.00 | 850.50 | 0.8207 | 0.6833 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 625.00 | 384.25 | 596.00 | 850.50 | 0.7008 | 0.4666 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 791.00 | 850.50 | 0.9300 | 0.8774 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 824.00 | 850.50 | 0.9688 | 0.9455 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 1024.00 | 850.50 | 1.2040 | 1.3516 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 625.00 | 384.25 | 957.00 | 850.50 | 1.1252 | 1.2168 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 625.00 | 384.25 | 510.00 | 850.50 | 0.5997 | 0.2802 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 838.00 | 850.50 | 0.9853 | 0.9743 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 625.00 | 384.25 | 997.00 | 850.50 | 1.1723 | 1.2974 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 1070.00 | 850.50 | 1.2581 | 1.4435 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 625.00 | 384.25 | 1015.00 | 850.50 | 1.1934 | 1.3336 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 625.00 | 384.25 | 358.00 | 850.50 | 0.4209 | -0.0599 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 625.00 | 384.25 | 748.00 | 850.50 | 0.8795 | 0.7880 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 512.00 | 850.50 | 0.6020 | 0.2846 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 625.00 | 384.25 | 388.00 | 850.50 | 0.4562 | 0.0085 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 625.00 | 384.25 | 1095.00 | 850.50 | 1.2875 | 1.4933 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 926.00 | 850.50 | 1.0888 | 1.1540 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 625.00 | 384.25 | 558.00 | 850.50 | 0.6561 | 0.3847 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 620.00 | 850.50 | 0.7290 | 0.5180 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 625.00 | 384.25 | 930.00 | 850.50 | 1.0935 | 1.1622 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 625.00 | 384.25 | 396.00 | 850.50 | 0.4656 | 0.0266 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 699.00 | 850.50 | 0.8219 | 0.6854 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 859.00 | 850.50 | 1.0100 | 1.0174 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1944.00 | 2319.50 | 0.8381 | 0.7589 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1757.00 | 2319.50 | 0.7575 | 0.6342 |